Sanofi Consumer Healthcare India Limited
₹3,435.05-₹32.90 (-0.9%)
Last close · Data as of Oct 30, 2026
- Market cap
- ₹9,742 Cr
- P/E
- 45.3x
- Revenue
- ₹724 Cr
Price chart
Technical chartScreen technicals →-26.2% over the last year
Daily closes.
Go deeper
Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools
Performance
Price change over each period, before dividends.
- 1M
- -9.8%
- 3M
- -25.6%
- 6M
- -27.9%
- 1Y
- -26.2%
- 5Y
- -29.9%
52-week range
Day change -₹32.90 (-0.9%) from ₹3,468 to ₹3,435 · Last close Oct 30, 2026
Best weekday to invest, historically
The same weekly amount in SANOFICONR, bought on each weekday since 2024.
AI Summary
Indian StockStrengths1
- Revenue grew 30.5% YoY
Concerns0
Rule-based from financial data. Not advice.
About the company
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited is a subsidiary of Opella Healthcare Participations B.V.
- Sector
- Healthcare
- Shares outstanding
- 2.3 Cr shares
- ISIN
- INE0UOS01011
- BSE code
- 544250
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- ₹9,742 Cr
- P/E
- 45.3x
- P/B
- 37.8x
- Earnings yield
- 2.2%
- 52-week high
- ₹5,037.90
- 52-week low
- ₹3,212.45
Growth
- RevenueLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹724 Cr
- Revenue growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 30.5%
- Net profit growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 9.7%
Revenue and net profit
Annual revenue, with net profit as the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2024 | ₹724 Cr | ₹181 Cr |
Cash flows
Cash from operations, with free cash flow as the dashed line.
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2023 | ₹0 Cr | ₹0 Cr |
| FY2024 | ₹439 Cr | ₹441 Cr |
Growth
Latest fiscal year FY2025 (ending March): each figure with its change over the year before.
| Year | Revenue | Operating income | EBITDA | Net profit | CFO | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | — | — | — | — | — | — | — | — | — |
Monthly returns
Month-by-month returns of SANOFICONR across the years, with the seasonal pattern.
Market cap against peers
8 peers: same sector group, nearest by size.
P/E against peers
SANOFICONR trades at 45.3x earnings against a peer median of 52.6x (a 14% discount).
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Sanofi Consumer Healthcare India LimitedSANOFICONRthis companyP/E ↓ discount | ₹9,742 Cr | 45.3x | 37.8x | — | — |
| Vijaya Diagnostic Centre LimitedVIJAYA | ₹10,297 Cr | 69.2x | 12.1x | 17.6% | 45.6x |
| Metropolis Healthcare LimitedMETROPOLIS | ₹9,882 Cr | 74.0x | 7.4x | 11.3% | 36.5x |
| JYOTHY LABS LIMITEDJYOTHYLAB | ₹9,555 Cr | 27.2x | 6.6x | 32.4% | 17.6x |
| HealthCare Global Enterprises LimitedHCG | ₹9,408 Cr | 513.0x | 8.0x | 2.8% | 49.9x |
| Sanofi India LtdSANOFI | ₹9,387 Cr | 25.4x | 12.0x | — | — |
| Jeena Sikho Lifecare LimitedJSLL | ₹8,968 Cr | 58.2x | 25.2x | 35.9% | 90.3x |
| PROCTER & GAMBLE HEALTH LIMITEDPGHL | ₹8,946 Cr | 29.2x | 14.4x | — | — |
| Jupiter Life Line Hospitals LimitedJLHL | ₹8,877 Cr | 46.3x | 5.9x | 12.2% | 34.5x |
| Peer median | — | 52.6x | 5.9x | 12.1% | 38.3x |
Year-to-date ROI
SANOFICONR since 1 January, against earlier years.
Historical volatility
SANOFICONR's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.
Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.
| Line | FYundefined |
|---|---|
| RevenueSales | — |
| Costs | |
| Interest | — |
| Expenses | — |
| Operating profitOperating Profit | — |
| Other income and charges | |
| Profit before tax | — |
| Tax | |
| Net profitNet Profit | — |
| Per share |
Learn while you research
Academy chapters picked for Sanofi Consumer Healthcare India Limited and the metrics on this page.
- 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
- 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 03 Valuation Multiples ExplainedThis stock trades at a P/E of 45.3, learn when high multiples are justified.6 min read
- 04 Growth Investing30% revenue growth is in the top tier, learn how to value growth.7 min read
- 05 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 06 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read